Succeeding in the AFP Test Volume and Sales Forecasts: US, Europe, Japan-Hospitals, Commercial Labs, POC Locations

Report
June 2019
Region: Europe, United States
VPG Market Research
ID: 4116493

This new report from the author provides analysis of AFP testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

Geographic Coverage
France, Germany, Italy, Japan, Spain, UK, USA

Market Segmentation
Centralized Testing

Hospitals

Commercial/Private Laboratories

POC/Decentralized Testing

Physician Offices/Group Practices

Cancer Clinics

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€730EUR$750USD£625GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€1605EUR$1,650USD£1,375GBP

Related Topics

Related Reports

2023 AFP Testing Market: US, Europe, Japan - Supplier Shares, Volume and Sales Segment Forecasts - Hospitals, Commercial Labs, POC Locations

2024 World Immunoassay Analyzers and Reagents in 98 Countries - Supplier Shares and Competitive Analysis, 2023-2028

The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition

Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028

Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027